Apolipoprotein E and tau protein in vascular dementia;Apolipoproteina E i bałko tau w otȩpieniu naczyniowym

Polski Merkuriusz Lekarski

Volumn 15, Issue 85, 2003, Pages 69-71

  Paradowski, Bogusław ^a   Dobosz, Tadeusz ^a   Sa̧siadek, Maria ^a   Szczepaniak, Małgorzata ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

ApoE; Tau protein; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN;

ALLELE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENOTYPE; HUMAN; MALE; MULTIINFARCT DEMENTIA; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; AGED; METABOLISM;

AGED; ALLELES; APOLIPOPROTEINS E; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; TAU PROTEINS;

EID: 0042235380     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Andreasen N. i wsp.: Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer disease: a community based follow up study. J. Neurol. Neurosurg. Psychiatry, 1998, 64, 298-305.
2. Betard C. i wsp.: ApoE allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport., 1994, 5, 1893-1896.
3. Corey-Bloom J. i wsp.: Diagnosis and evaluation of dementia. Neurology, 1995, 70, 989-998.
4. Fisher C.M.: Dementia in cerebrovascular disease. W: Cerebral vascular disease. Grune i Stratton, New York. 1968, 232-236.
5. Folstein M.F., Folstein S.E., Mc Hugh P.R.: A practical method grading the cognitive state of patients for the clinician. J. Psychiatr. Res., 1975, 12, 189-198.
6. Frisoni G.B. i wsp.: Apolipoprotein E epsilon 4 allele in Alzheimer's disease and Vascular dementia. Dementia, 1994, 5, 240-242.
7. Hachinski V.C. i wsp.: Cerebral blood flow in dementia. Arch. Neurol., 1975, 32, 632-637.
8. Hachinski V.C., Lassen N.A., Marshall J.: Multi-infarct-dementia. Lancet, 1974, 207-210.
9. Higuchi S. i wsp.: The apolipoprotein E gene in Binswanger's disease and vascular dementia. Clin. Genet., 1996, 50, 459-461.
10. Holmes C. i wsp.: Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br. J. Psychiatry, 1999, 174, 45-50.
11. Kawamata J. i wsp.: Apolipoprotein E polymorphism in Japanese patients witch Alzheimere's disease or vascular dementia. J. Neurol. Neurosurg. Psychiatry, 1994, 57, 1414-1416.
12. Knijff P., Havekes L.M.: Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach. Curr. Opin. Lipidol., 1996, 7, 59-63.
13. Landen M. i wsp.: The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry, 1996, 61, 352-356.
14. Lim A. i wsp.: Clinico-neuropathological corelation of Aizheimere's disease in a community-based case series. J. Am. Geriatr. Soc., 1999, 47, 564-569.
15. Mahley R.W. i wsp.: Apolipoprotein E: impact of cytoskeletal stability in neurons and the retationship to Alzheimer's disease. Curr. Opin. Lipidol., 1995, 6, 86-91.
16. Marin D.B. i wsp.: The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis, 1998, 140, 173-180.
17. Paradowski B. i wsp.: Apolipoproteina (ApoE) i białko tau w otȩpieniu typu Alzheimera. Pol. Merk. Lek., 2000, 53, 758-759.
18. Roman G.C. i wsp.: Vascular dementia:diagnostic criteria for research studies; raport of the NINDS-AIREN International Work-shop. Neurology, 1993, 43, 250-260.
19. Schmidt R.F. i wsp.: ApoE genotype predicts AD and other dementia but not ischemic cerebrovascular disease. Neurology, 2001, 56, 194-200.
20. Stenegard J.H. i wsp.: Apolipoprotein E polimorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neuro. Scand., 1995, 92, 297-298.
21. Wilson P.W.: Apolipoprotein E alleles and risk of coronary disease. A metaanalysis. Arterioscler. Thromb. Vasc. Biol., 1996, 16, 1250-1255.